Effects of WIN 55,212-2 (a non-selective cannabinoid CB1 and CB2 receptor agonist) on the protective action of various classical antiepileptic drugs in the mouse 6 Hz psychomotor seizure model

Journal of Neural Transmission

Volumn 121, Issue 7, 2014, Pages 707-715

  Florek Luszczki, Magdalena ^a   Wlaz, Aleksandra ^b   Kondrat Wrobel, Maria W ^b   Tutka, Piotr ^c   Luszczki, Jarogniew J ^a,b  

^a INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c UNIVERSITY OF RZESZÓW   (Poland)

Author keywords

6 Hz psychomotor seizure model; Antiepileptic drugs; Cannabinoids; Drug interactions; WIN 55,212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CLOBAZAM; CLONAZEPAM; PHENOBARBITAL; VALPROIC ACID; ANTICONVULSIVE AGENT; BENZOXAZINE DERIVATIVE; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE; NEUROPROTECTIVE AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN PROTECTION; CHIMNEY TEST; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG POTENTIATION; ELECTRODE; EXPERIMENTAL SEIZURE; FLUORESCENCE POLARIZATION IMMUNOASSAY; GRIP STRENGTH TEST; LEARNING; MALE; MOTOR COORDINATION; MOTOR PERFORMANCE; MOUSE; MUSCLE STRENGTH; NEUROPROTECTION; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; ANALYSIS OF VARIANCE; ANIMAL; AVOIDANCE BEHAVIOR; BIOPHYSICS; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; ELECTROSHOCK; EPILEPSY, COMPLEX PARTIAL; PSYCHOMOTOR PERFORMANCE;

ANALYSIS OF VARIANCE; ANIMALS; ANTICONVULSANTS; AVOIDANCE LEARNING; BENZOXAZINES; BIOPHYSICS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; EPILEPSY, COMPLEX PARTIAL; MALE; MICE; MORPHOLINES; MUSCLE STRENGTH; NAPHTHALENES; NEUROPROTECTIVE AGENTS; PSYCHOMOTOR PERFORMANCE;

EID: 84903278372     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-014-1173-7     Document Type: Article

References (23)

1. Barton ME, Klein BD, Wolf HH, White HS (2001) Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy. Epilepsy Res 47:217-227 (Pubitemid 34008465)
2. Baur R, Gertsch J, Sigel E (2012) The cannabinoid CB1 receptor antagonists rimonabant (SR141716) and AM251 directly potentiate GABA(A) receptors. Br J Pharmacol 165:2479-2484
3. Baur R, Kielar M, Richter L, Ernst M, Ecker GF, Sigel E (2013) Molecular analysis of the site for 2-arachidonylglycerol (2-AG) on the β2 subunit of GABA(A) receptors. J Neurochem 126:29-36
4. Boissier JR, Tardy J, Diverres JC (1960) Une nouvelle méthode simple pour explorer l'action tranquilisante: le test de la cheminée. Med Exp (Basle) 3:81-84
5. Brown WC, Schiffman DO, Swinyard EA, Goodman LS (1953) Comparative assay of an antiepileptic drugs by psychomotor seizure test and minimal electroshock threshold test. J Pharmacol Exp Ther 107:273-283
6. Doi T, Ueda Y, Tokumaru J, Willmore LJ (2005) Molecular regulation of glutamate and GABA transporter proteins by clobazam during epileptogenesis in Fe(+++)-induced epileptic rats. Mol Brain Res 142:91-96 (Pubitemid 41681276)
7. Florek-Luszczki M, Wlaz A, Luszczki JJ (2014) Interactions of levetiracetam with carbamazepine, phenytoin, topiramate and vigabatrin in the mouse 6 Hz psychomotor seizure model - A type II isobolographic analysis. Eur J Pharmacol 723:410-418
8. Kovacs FE, Knop T, Urbanski MJ, Freiman I, Freiman TM, Feuerstein TJ, Zentner J, Szabo B (2012) Exogenous and endogenous cannabinoids suppress inhibitory neurotransmission in the human neocortex. Neuropsychopharmacology 37:1104-1114
9. Litchfield JT, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99-113
10. Luszczki JJ, Antkiewicz-Michaluk L, Czuczwar SJ (2009) Isobolographic analysis of interactions between 1-methyl-1,2,3,4-tetra-hydroisoquinoline and four conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Eur J Pharmacol 602:298-305
11. Luszczki JJ, Trojnar MK, Ratnaraj N, Patsalos PN, Czuczwar SJ (2010) Interactions of stiripentol with clobazam and valproate in the mouse maximal electroshock-induced seizure model. Epilepsy Res 90:188-198
12. Luszczki JJ, Andres-Mach M, Barcicka-Klosowska B, Florek-Luszczki M, Haratym-Maj A, Czuczwar SJ (2011a) Effects of WIN 55,212-2 mesylate (a synthetic cannabinoid) on the protective action of clonazepam, ethosuximide, phenobarbital and valproate against pentylenetetrazole-induced clonic seizures in mice. Prog Neuropsychopharmacol Biol Psychiatry 35:1870-1876
13. Luszczki JJ, Misiuta-Krzesinska M, Florek M, Tutka P, Czuczwar SJ (2011b) Synthetic cannabinoid WIN 55,212-2 mesylate enhances the protective action of four classical antiepileptic drugs against maximal electroshock-induced seizures in mice. Pharmacol Biochem Behav 98:261-267
14. Luszczki JJ, Wlaz A, Karwan S, Florek-Luszczki M, Czuczwar SJ (2013) Effects of WIN 55,212-2 mesylate on the anticonvulsant action of lamotrigine, oxcarbazepine, pregabalin and topiramate against maximal electroshock-induced seizures in mice. Eur J Pharmacol 720:247-254
15. Meyer OA, Tilson HA, Byrd WC, Riley MT (1979) A method for the routine assessment of fore-and hindlimb grip strength of rats and mice. Neurobehav Toxicol 1:233-236 (Pubitemid 11204691)
16. Naderi N, Aziz Ahari F, Shafaghi B, Najarkolaei AH, Motamedi F (2008) Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice. J Neural Transm 115:1501-1511
17. Ng YT, Collins SD (2007) Clobazam. Neurotherapeutics 4:138-144
18. Patsalos PN (2005) Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies. Epilepsia 46(Suppl 9):140-148
19. Rowley NM, White HS (2010) Comparative anticonvulsant efficacy in the corneal kindled mouse model of partial epilepsy: correlation with other seizure and epilepsy models. Epilepsy Res 92:163-169
20. Schmidt D (2002) Clinical efficacy and use in epilepsy. In: Levy RH, Mattson RH, Meldrum BS, Perucca E (eds) Antiepileptic drugs, 5th edn. Lippincott Williams and Wilkins, Philadelphia, pp 206-214
21. Sigel E, Baur R, Rácz I, Marazzi J, Smart TG, Zimmer A, Gertsch J (2011) The major central endocannabinoid directly acts at GABA(A) receptors. Proc Natl Acad Sci USA 108:18150-18155
22. Smith M, Wilcox KS, White HS (2007) Discovery of antiepileptic drugs. Neurotherapeutics 4:12-17
23. Venault P, Chapouthier G, de Carvalho LP, Simiand J, Morre M, Dodd RH, Rossier J (1986) Benzodiazepines impair and betacarbolines enhance performance in learning and memory tasks. Nature 321:864-866 (Pubitemid 16097728)